MF研究者総覧

教員活動データベース

<Editors' Choice> Treatment strategy for upper cervical epidural abscess: a literature review

発表形態:
原著論文
主要業績:
主要業績
単著・共著:
共著
発表年月:
2021年02月
DOI:
10.18999/nagjms.83.1.1
会議属性:
指定なし
査読:
有り
リンク情報:

日本語フィールド

著者:
*Takaomi Kobayashi, Hiroshi Ureshino, Tadatsugu Morimoto, Chisato Shimanoe, Ko Ikuta, Motoki Sonohata, Masaaki Mawatari
題名:
<Editors' Choice> Treatment strategy for upper cervical epidural abscess: a literature review
発表情報:
Nagoya J Med Sci 巻: 83 号: 1 ページ: 1-20
キーワード:
antibiotics; paralysis; surgery; upper cervical epidural abscess; weakness
概要:
We aimed to determine available evidences in the literature regarding surgical approaches and methods, timing of surgical interventions, duration of perioperative antibiotics, and duration of nonsurgical treatments (antibiotics administration) in patients with upper cervical (occiput-C2) epidural abscess (UCEA). We performed a literature review of the articles on surgical interventions and antibiotic therapy to treat UCEA, searching the PubMed database for relevant articles published in the English language (as of March 2020). In total, 53 patients with UCEA were identified. Permanent limb paralysis or death was observed in 1/15 (6.7%) patients who received the transoral approach and 2/15 (13.3%) patients who received the transcervical approach, 1/26 (3.8%) patients who underwent surgery before the onset of paralysis, and 2/4 (50.0%) patients who underwent surgery after the onset of paralysis. In 85%-89% of cases, antibiotic administration was continued for 6-12 weeks, which was determined by the confirmation of reduced inflammatory response and/or abscess disappearance on imaging. Differences in surgical approaches may not be associated with the incidence of permanent limb paralysis or death. Surgical interventions before limb paralysis onset are recommended in UCEA patients. In perioperative and nonoperative treatments, antibiotic administration for 6-12 weeks may be supported based on the confirmation of reduced inflammatory response and/or abscess disappearance on imaging. Further investigations are needed.
抄録:

英語フィールド

Author:
*Takaomi Kobayashi, Hiroshi Ureshino, Tadatsugu Morimoto, Chisato Shimanoe, Ko Ikuta, Motoki Sonohata, Masaaki Mawatari
Title:
<Editors' Choice> Treatment strategy for upper cervical epidural abscess: a literature review
Announcement information:
Nagoya J Med Sci Vol: 83 Issue: 1 Page: 1-20
Keyword:
antibiotics; paralysis; surgery; upper cervical epidural abscess; weakness
An abstract:
We aimed to determine available evidences in the literature regarding surgical approaches and methods, timing of surgical interventions, duration of perioperative antibiotics, and duration of nonsurgical treatments (antibiotics administration) in patients with upper cervical (occiput-C2) epidural abscess (UCEA). We performed a literature review of the articles on surgical interventions and antibiotic therapy to treat UCEA, searching the PubMed database for relevant articles published in the English language (as of March 2020). In total, 53 patients with UCEA were identified. Permanent limb paralysis or death was observed in 1/15 (6.7%) patients who received the transoral approach and 2/15 (13.3%) patients who received the transcervical approach, 1/26 (3.8%) patients who underwent surgery before the onset of paralysis, and 2/4 (50.0%) patients who underwent surgery after the onset of paralysis. In 85%-89% of cases, antibiotic administration was continued for 6-12 weeks, which was determined by the confirmation of reduced inflammatory response and/or abscess disappearance on imaging. Differences in surgical approaches may not be associated with the incidence of permanent limb paralysis or death. Surgical interventions before limb paralysis onset are recommended in UCEA patients. In perioperative and nonoperative treatments, antibiotic administration for 6-12 weeks may be supported based on the confirmation of reduced inflammatory response and/or abscess disappearance on imaging. Further investigations are needed.


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.